×
About 3,163 results

ALLMedicine™ Interstitial Lung Disease Center

Research & Reviews  1,208 results

Evaluation of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies Through S...
https://doi.org/10.1097/RTI.0000000000000659
Journal of Thoracic Imaging; Roncella C, Barsotti S et. al.

May 17th, 2022 - To perform a semiquantitative and quantitative analysis of interstitial lung disease (ILD), through computed tomography (CT), in different serological subgroups of idiopathic inflammatory myopathies (IIM) patients, to find radiologic and clinical ...

Assessing the diagnostic value of a potential screening tool for detecting early inters...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097403
Arthritis Research & Therapy; Hoffmann T, Oelzner P et. al.

May 14th, 2022 - Interstitial lung disease (ILD) is a severe pulmonary complication in inflammatory rheumatic diseases (IRD) and associated with significantly increased morbidity and mortality. That is why ILD screening at a very early stage, at the onset of IRD, ...

A case of adenoviral covid-19 vector vaccine possibly linked to severe but reversible i...
https://doi.org/10.1080/23744235.2022.2072521
Infectious Diseases (London, England); Liatsos GD, Mavroudis A et. al.

May 13th, 2022 - Several safe and effective vaccines against nCoV-19 have been developed to contain the pandemic with very few severe adverse-reactions reported. Vaccine-induced interstitial lung disease (ILD) is a very rare and difficult to recognise and diagnose...

Association between bevacizumab with cancer drug therapies and drug-induced interstitia...
https://doi.org/10.1016/j.critrevonc.2022.103703
Critical Reviews in Oncology/hematology; Nozawa K, Takatsuka D et. al.

May 10th, 2022 - This study aimed to determine interstitial lung disease (ILD) incidences in patients receiving cancer drug therapies with or without bevacizumab treatment. Systematic searches of PubMed, Embase, and Cochrane Library were conducted in January 2021....

Multidisciplinary Care and Prognosis in Patients With COPD and Interstitial Lung Diseas...
https://doi.org/10.4187/respcare.09446
Respiratory Care; Harrison AC, Robinson JF et. al.

May 4th, 2022 - Home oxygen therapy is prescribed for patients with advanced lung disease based on the criteria established in landmark trials in subjects with COPD. In clinical practice, its use has been extrapolated to other diseases, including interstitial lun...

see more →

Guidelines  1 results

Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: CHEST Guidel...
https://doi.org/10.1016/j.chest.2019.10.048
Chest Maldonado F, Danoff SK et. al.

Nov 30th, 2019 - Transbronchial cryobiopsy (TBC) is increasingly recognized as a potential alternative to surgical lung biopsy (SLB) for the diagnosis of interstitial lung disease (ILD). The goal of this analysis was to examine the literature on TBC as it relates ...

see more →

Drugs  3 results see all →

News  53 results

Cough-Specific QOL Linked to Poor Outcomes in ILD Patients
https://www.medscape.com/viewarticle/972378

Apr 19th, 2022 - Poor cough-specific quality of life (QOL) was independently associated with respiratory hospitalization, death, and lung transplantation in a large population of well-characterized patients with interstitial lung disease (ILD), new research shows....

ILD Progression, Not Diagnosis, Triggers Palliative Care
https://www.medscape.com/viewarticle/971542

Apr 4th, 2022 - Most healthcare providers are comfortable recommending palliative care (PC) for their patients with interstitial lung disease (ILD), but most do so at the time of disease progression, rather than diagnosis, as indicated on survey data from 128 cli...

Treating Systemic Sclerosis Interstitial Lung Disease: Evidence on Best Uses of Newly Approved Drugs
https://www.medscape.com/viewarticle/970417

Mar 22nd, 2022 - Kimberly Showalter, MD, MS Interstitial lung disease (ILD) is a frequent complication of systemic sclerosis (SSc) as well as a leading cause of death in this population. Nintedanib (Ofev) and tocilizumab (Actemra) are both recently approved treatm...

ICIs for NSCLC: Patients With ILD Show Greater Risk
https://www.medscape.com/viewarticle/967351

Jan 26th, 2022 - Immune checkpoint inhibitors (ICIs) are at least as effective in patients with advanced non-small cell lung cancer (NSCLC) and mild preexisting interstitial lung disease (ILD) as those without ILD. However, the risk of checkpoint inhibitor pneumon...

Detecting Connective Tissue Disease-Associated Interstitial Lung Disease: What Are Current Screening Strategies?
https://www.medscape.com/viewarticle/966769

Jan 19th, 2022 - Dr Kimberly Showalter Interstitial lung disease (ILD) is a leading cause of morbidity and mortality among individuals with systemic sclerosis (SSc)1 and also negatively affects survival for those with other connective tissue diseases (CTD), includ...

see more →